Qnasl Pregnancy Warnings
Benefit should outweigh risk
US FDA pregnancy category: C
Comments:
-Hypoadrenalism may occur in infants born of mothers taking corticosteroids during pregnancy.
-These infants should be carefully monitored.
Animal studies have shown that subcutaneous administration produced fetal toxicity. There are no adequate and well-controlled studies in pregnant women on the teratogenic effects from this drug.
US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.
See references
